FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ryan Timothy John
2. Issuer Name and Ticker or Trading Symbol

Exactus, Inc. [ EXDI ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EXECUTIVE VICE PRESIDENT
(Last)          (First)          (Middle)

4870 SADLER RD, SUITE 300
3. Date of Earliest Transaction (MM/DD/YYYY)

9/4/2018
(Street)

GLEN ALLEN, VA 23060
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

9/14/2018 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy)   (1) $0.089   9/4/2018     A      225000       9/4/2018   9/4/2023   Common Stock   225000     (2) 225000   D  
 
Series D Preferred Stock (the   (3)   (4) 9/12/2018     D         16    7/5/2018     (5) Common Stock   3200000     (6) 11   (7) D  
 

Explanation of Responses:
(1)  178,125 stock options are fully vested with the remainder vesting monthly in equal increments over a 15 month period beginning on October 1, 2018, subject to execution of the Company's standard stock option agreement and continued service as an officer of the Company on each applicable vesting date.
(2)  Not applicable.
(3)  On the Transaction Date, the Purchaser entered into an Agreement to unwind and terminate the Series D Subscription Agreement and void the issuance of the Series D Preferred Stock. The sale was approved in advance by the board of directors of the Company and therefore exempt pursuant to Rule 16b-3(e).
(4)  Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000.
(5)  The Series D has no expiration date.
(6)  The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $200,000.
(7)  The original Form 4 filed on September 14, 2018, is amended by this Form 4, which corrects Table II Item 9 to show that the Reporting Person beneficially owns 11 shares of Series D following the reported transaction. No other changes have been made to the original Form 4.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ryan Timothy John
4870 SADLER RD
SUITE 300
GLEN ALLEN, VA 23060
X X EXECUTIVE VICE PRESIDENT

Signatures
/s/ Timothy J. Ryan 9/14/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.